A New Foundational Platform for Biology: Cellanome’s Debut with CEO Omead Ostadan

Few startups have launched with such quiet anticipation—or such a remarkable founding pedigree—as Cellanome. Backed by veterans of the genomics revolution, the company aims to do for cell biology what Illumina did for sequencing: make it measurable, dynamic, and multidimensional.In this debut conversation, Cellanome CEO Omead Ostadan traces his path from the early days of Applied Biosystems and Solexa to what he calls “the multi-omics of the cell.” He describes a breakthrough platform capable of observing living cells in real time, combining imaging, molecular analysis, and computation in ways that bring biology closer than ever to its native state.“Our hypothesis,” says Ostadan, “is that you are now creating an environment that most resembles the natural environment in which these cells operate. Anything you’re measuring is much more likely to resemble what you’re going to see in real biology.”Using what the company calls CellCage technology, the Cellanome R3200 system can isolate and sustain thousands of living cells or co-cultures—neurons with microglia, for instance—allowing researchers to track interactions, responses, and phenotypic changes over time. Ostadan believes this kind of structured, longitudinal, multimodal data will be foundational for the next generation of AI-driven biological models.“The next leap in biology,” he says, “requires a fundamentally different mode of data. That has been our focus from the start—to generate data that most closely resembles what’s happening at the foundational basis of biology across all organisms.”Now in full commercialization, Cellanome has multiple units installed in the U.S. and preparing for expansion into Europe and Asia. For Ostadan, who has helped bring multiple life-science platforms to market, this moment feels singular: “I’ve never been as excited about the potential of a technology as I am about what we have at Cellanome,” he says. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe